Bruce Y Lee1, Leila A Haidari2, Wendy Prosser3, Diana L Connor4, Ruth Bechtel3, Amelia Dipuve5, Hidayat Kassim6, Balbina Khanlawia7, Shawn T Brown2. 1. Public Health Computational and Operations Research (PHICOR) and Global Obesity Prevention Center (GOPC), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: brucelee@jhu.edu. 2. Pittsburgh Supercomputer Center, Carnegie Mellon University, Pittsburgh, PA, USA. 3. VillageReach, Seattle, WA, USA. 4. Public Health Computational and Operations Research (PHICOR) and Global Obesity Prevention Center (GOPC), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 5. Provincial Directorate of Health, Gaza, Mozambique. 6. Provincial Directorate of Health, Cabo Delgado, Mozambique. 7. Mozambique Ministry of Health, Maputo, Mozambique.
Abstract
INTRODUCTION: Populations and routine childhood vaccine regimens have changed substantially since supply chains were designed in the 1980s, and introducing new vaccines during the "Decade of Vaccine" may exacerbate existing bottlenecks, further inhibiting the flow of all vaccines. METHODS: Working with the Mozambique Ministry of Health, our team implemented a new process that integrated HERMES computational simulation modeling and on-the-ground implementers to evaluate and improve the Mozambique vaccine supply chain using a system-re-design that integrated new supply chain structures, information technology, equipment, personnel, and policies. RESULTS: The alternative system design raised vaccine availability (from 66% to 93% in Gaza; from 76% to 84% in Cabo Delgado) and reduced the logistics cost per dose administered (from $0.53 to $0.32 in Gaza; from $0.38 to $0.24 in Cabo Delgado) as compared to the multi-tiered system under the current EPI. The alternative system also produced higher availability at lower costs after new vaccine introductions. Since reviewing scenarios modeling deliveries every two months in the north of Gaza, the provincial directorate has decided to pilot this approach diverging from decades of policies dictating monthly deliveries. DISCUSSION: Re-design improved not only supply chain efficacy but also efficiency, important since resources to deliver vaccines are limited. The Mozambique experience and process can serve as a model for other countries during the Decade of Vaccines. For the Decade of Vaccines, getting vaccines at affordable prices to the market is not enough. Vaccines must reach the population to be successful.
INTRODUCTION: Populations and routine childhood vaccine regimens have changed substantially since supply chains were designed in the 1980s, and introducing new vaccines during the "Decade of Vaccine" may exacerbate existing bottlenecks, further inhibiting the flow of all vaccines. METHODS: Working with the Mozambique Ministry of Health, our team implemented a new process that integrated HERMES computational simulation modeling and on-the-ground implementers to evaluate and improve the Mozambique vaccine supply chain using a system-re-design that integrated new supply chain structures, information technology, equipment, personnel, and policies. RESULTS: The alternative system design raised vaccine availability (from 66% to 93% in Gaza; from 76% to 84% in Cabo Delgado) and reduced the logistics cost per dose administered (from $0.53 to $0.32 in Gaza; from $0.38 to $0.24 in Cabo Delgado) as compared to the multi-tiered system under the current EPI. The alternative system also produced higher availability at lower costs after new vaccine introductions. Since reviewing scenarios modeling deliveries every two months in the north of Gaza, the provincial directorate has decided to pilot this approach diverging from decades of policies dictating monthly deliveries. DISCUSSION: Re-design improved not only supply chain efficacy but also efficiency, important since resources to deliver vaccines are limited. The Mozambique experience and process can serve as a model for other countries during the Decade of Vaccines. For the Decade of Vaccines, getting vaccines at affordable prices to the market is not enough. Vaccines must reach the population to be successful.
Authors: Bruce Y Lee; Benjamin Schreiber; Angela R Wateska; Diana L Connor; Hamadou M Dicko; Philippe Jaillard; Mercy Mvundura; Carol Levin; Mélanie Avella; Leila A Haidari; Shawn T Brown Journal: Vaccine Date: 2015-04-18 Impact factor: 3.641
Authors: Bruce Y Lee; Diana L Connor; Angela R Wateska; Bryan A Norman; Jayant Rajgopal; Brigid E Cakouros; Sheng-I Chen; Erin G Claypool; Leila A Haidari; Veena Karir; Jim Leonard; Leslie E Mueller; Proma Paul; Michelle M Schmitz; Joel S Welling; Yu-Ting Weng; Shawn T Brown Journal: Vaccine Date: 2015-07-23 Impact factor: 3.641
Authors: Shawn T Brown; Benjamin Schreiber; Brigid E Cakouros; Angela R Wateska; Hamadou M Dicko; Diana L Connor; Philippe Jaillard; Mercy Mvundura; Bryan A Norman; Carol Levin; Jayant Rajgopal; Mélanie Avella; Caroline Lebrun; Erin Claypool; Proma Paul; Bruce Y Lee Journal: Vaccine Date: 2014-05-09 Impact factor: 3.641
Authors: Bruce Y Lee; Brigid E Cakouros; Tina-Marie Assi; Diana L Connor; Joel Welling; Souleymane Kone; Ali Djibo; Angela R Wateska; Lionel Pierre; Shawn T Brown Journal: Vaccine Date: 2012-07-10 Impact factor: 3.641
Authors: Tina-Marie Assi; Shawn T Brown; Ali Djibo; Bryan A Norman; Jayant Rajgopal; Joel S Welling; Sheng-I Chen; Rachel R Bailey; Souleymane Kone; Hailu Kenea; Diana L Connor; Angela R Wateska; Anirban Jana; Stephen R Wisniewski; Willem G Van Panhuis; Donald S Burke; Bruce Y Lee Journal: BMC Public Health Date: 2011-06-02 Impact factor: 3.295
Authors: Leila A Haidari; Diana L Connor; Angela R Wateska; Shawn T Brown; Leslie E Mueller; Bryan A Norman; Michelle M Schmitz; Proma Paul; Jayant Rajgopal; Joel S Welling; Jim Leonard; Sheng-I Chen; Bruce Y Lee Journal: PLoS One Date: 2013-05-22 Impact factor: 3.240
Authors: Bruce Y Lee; Patrick T Wedlock; Leila A Haidari; Kate Elder; Julien Potet; Rachel Manring; Diana L Connor; Marie L Spiker; Kimberly Bonner; Arjun Rangarajan; Delphine Hunyh; Shawn T Brown Journal: Vaccine Date: 2017-04-25 Impact factor: 3.641
Authors: Marie C Ferguson; Matthew J Morgan; Kelly J O'Shea; Lucas Winch; Sheryl S Siegmund; Mario Solano Gonzales; Samuel Randall; Daniel L Hertenstein; Valerie Montague; Ayanna Woodberry; Trish Cassatt; Bruce Y Lee Journal: Obesity (Silver Spring) Date: 2020-05-07 Impact factor: 5.002
Authors: Sarah N Cox; Patrick T Wedlock; Sarah W Pallas; Elizabeth A Mitgang; Tatenda T Yemeke; Sarah M Bartsch; Taiwo Abimbola; Sheryl S Sigemund; Aaron Wallace; Sachiko Ozawa; Bruce Y Lee Journal: Vaccine Date: 2021-05-25 Impact factor: 3.641
Authors: Bruce Y Lee; Patrick T Wedlock; Elizabeth A Mitgang; Sarah N Cox; Leila A Haidari; Manoja K Das; Srihari Dutta; Bhrigu Kapuria; Shawn T Brown Journal: BMJ Glob Health Date: 2019-09-05
Authors: Patrick T Wedlock; Elizabeth A Mitgang; Assaf P Oron; Brittany L Hagedorn; Jim Leonard; Shawn T Brown; Jennifer Bakal; Sheryl S Siegmund; Bruce Y Lee Journal: Vaccine Date: 2019-03-23 Impact factor: 3.641
Authors: Patrick T Wedlock; Elizabeth A Mitgang; Sheryl S Siegmund; Jay DePasse; Jennifer Bakal; Jim Leonard; Joel Welling; Shawn T Brown; Bruce Y Lee Journal: Vaccine Date: 2018-08-23 Impact factor: 3.641